Neoadjuvant abiraterone acetate plus leuprolide acetate in localised high-risk prostate cancer | Dr Eleni Efstathiou at ASCO 2015
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Eleni Efstathiou, MD, PhD, of The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the results of a study ...
Author: EMJ
Added: 07/16/2015
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Abiraterone Acetate | Cancer | Cancer & Oncology | Neoadjuvant Therapy | Prostate Cancer | Study | Texas University